Meiwei Dental Group

Meiwei Dental Group aims to revolutionize comprehensive oral health management through prevention and innovation. Affiliated with Tianyi Group, the company has established China's first platform for oral medicine, leveraging strategic investment, standardized operations, and advanced medical technology to empower top domestic oral medical brands and experts. With the support of DNV GL, a globally recognized certification authority, Meiwei Dental has developed the "M+" management certification, driving scientific research, academic innovation, and talent cultivation. The company also emphasizes the importance of a comfortable medical environment and specialized services through its "business partner" mechanism, fostering a mutually beneficial community. Meiwei Dental has invested in and acquired 12 dental chain brands, spanning 35 cities and including 130 dental hospitals and clinics. In July 2021, the company secured a significant CNY 1.00B Series B investment from investors including New Hope Group, Fortune Venture Capital, Winfast Holding, TFTR Investment, and Ruihua Venture Capital. Meiwei Dental Group's strategic approach and rapid expansion in the private dental health sector highlight its potential for long-term success in the Health Care industry since its founding in 2015.

- - -

Overall, Meiwei Dental Group's innovative approach to oral health management, strategic partnerships, and rapid expansion in the private dental health sector position it as a promising investment opportunity. The company's focus on empowering top domestic oral medical brands and experts, along with its emphasis on certification, research, and community collaboration, reflects a strong commitment to excellence in the industry. The recent CNY 1.00B Series B investment from reputable investors further validates the company's potential for continued growth and success. As Meiwei Dental continues to expand its presence across 35 cities and enhance comprehensive health management through prevention, it presents an attractive opportunity for venture capital investors seeking to support innovative and impactful developments in the healthcare industry.